Most Recent

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By , and | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: Enhanced Enhancers

Enhanced Enhancers

By | November 1, 2014

The recent discovery of super-enhancers may offer new drug targets for a range of diseases.

0 Comments

image: The Great Divide

The Great Divide

By | December 1, 2013

A two-way bridge between science and policy is desperately needed.

2 Comments

image: Proceed with Caution

Proceed with Caution

By | October 1, 2013

While genomic data sharing is essential for research, scientists must work to keep sensitive, potentially damaging information under wraps.

1 Comment

image: Remaking Nature

Remaking Nature

By | August 1, 2013

Synthetic biologists need to work together with conservationists to understand the environmental consequences of this new technology.

6 Comments

image: Researchers, Hire Hackers

Researchers, Hire Hackers

By | May 1, 2013

Clinical researchers need programming support to streamline their work, minimize error in the data, and find new trends that can point to better treatments.

0 Comments

image: Border Buffers

Border Buffers

By | April 1, 2013

Protected areas help to conserve imperiled tropical forests, but many are struggling to sustain their resident species.

0 Comments

image: DIYbio: Low Risk, High Potential

DIYbio: Low Risk, High Potential

By | March 1, 2013

Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.

5 Comments

image: Regulating Amateurs

Regulating Amateurs

By | March 1, 2013

How should the government ensure the safety and responsibility of do-it-yourself biologists?

2 Comments

image: Variety Is the Spice of Life

Variety Is the Spice of Life

By | February 1, 2013

True understanding of the complexity of biological systems demands an assortment of model systems.

2 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech